US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Acurx Pharmaceuticals, LLC*

1.26

-0.0450-3.45%

Post-market: 1.280.0200+1.59%19:55 EDT

Volume:130.50K

Turnover:165.28K

Market Cap:6.89M

PE:-0.41

High:1.32

Open:1.32

Low:1.23

Close:1.31

52wk High:8.34

52wk Low:1.23

Shares:5.47M

Float Shares:5.34M

Volume Ratio:1.43

T/O Rate:2.44%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.0454

EPS(LYR):-5.3153

ROE:-128.11%

ROA:-55.92%

PB:0.85

PE(LYR):-0.24

Loading ...

Overview Company News Filings

Acurx Says FDA Open to Single Phase 3 Trial to Support Ibezapolstat CDI NDA Filing

Acurx Pharmaceuticals - Receives FDA Guidance on Single Phase 3 Trial Nda for Ibezapolstat in Cdi

THOMSON REUTERS

FDA Provides Further Regulatory Guidance to Acurx Pharmaceuticals for the Ibezapolstat Clinical Development Program, Including the Potential for a Single-Phase 3-Trial Registration Plan and a Trial Design to Support Both Treatment and Reduction of Recurrence of C. Difficile Infection

THOMSON REUTERS

Acurx Pharmaceuticals - FDA Agrees Nda Filing Possible for Both Treatment and Recurrence Reduction with Successful Trials

THOMSON REUTERS

Acurx Pharmaceuticals - FDA Open to Pre-Nda Discussion After Single Phase 3 Trial if Efficacy Results are Robust

THOMSON REUTERS

Acurx Launches Pilot Trial of Ibezapolstat in Multiply Recurrent C. Difficile Infection

Acurx Pharmaceuticals Posts Presentation on Ibezapolstat Microbiome Restoration Potential in Recurrent C. Difficile Infection

Acurx Pharmaceuticals to Discuss Q2 Financial Results on Conference Call

Acurx Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 14, 2026 Conference Call and Provide Business Update

THOMSON REUTERS

Acurx says lead antibiotic ibezapolstat is ready to enter pivotal Phase 3 trials for C. difficile infection

Acurx Pharmaceuticals Announces Presentation of Results From Leiden University Medical Center Public-Private Partnership for Its DNA Pol Iiic Inhibitors at the Leiden Early Drug Discovery & Development (Led3) Scientific Conference

THOMSON REUTERS

Analysts Conflicted on These Healthcare Names: Altimmune (ALT) and Acurx Pharmaceuticals (ACXP)

Analysts Are Bullish on Top Healthcare Stocks: Acurx Pharmaceuticals (ACXP), Neurogene (NGNE)

Acurx Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Acurx Pharmaceuticals Q1 EPS USD -0.62

THOMSON REUTERS

Acurx Q1 net loss narrows 22% to $1.68 million

Calendar of U.S. Earnings Expected in the Week Ahead

Acurx Pharmaceuticals Inc expected to post a loss of 63 cents a share - Earnings Preview

Acurx DNA pol IIIC inhibitors spare gut microbiome in MRSA mouse study, poster shows

Acurx CEO to join Alliance Global Partners Healthcare Company Showcase fireside chat

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/ACXP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACXP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACXP\",,,,,undefined,":{"symbol":"ACXP","market":"US","secType":"STK","nameCN":"Acurx Pharmaceuticals, LLC*","latestPrice":1.26,"timestamp":1790798400000,"preClose":1.305,"halted":0,"volume":130497,"hourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.26,"latestTime":"19:55 EDT","volume":591,"amount":755.78,"timestamp":1790812558759,"change":0.02,"changeRate":0.015873,"amplitude":0.015873},"delay":0,"changeRate":-0.0344827586206896,"floatShares":5342700,"shares":5471300,"eps":-3.0454,"marketStatus":"Not Yet Opened","change":-0.045,"latestTime":"09-30 16:00:00 EDT","open":1.32,"high":1.32,"low":1.23,"amount":165282.7892583,"amplitude":0.068966,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.0454,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":1.305,"preHourTrading":{"tag":"盘前","latestPrice":1.31,"preClose":1.305,"latestTime":"08:32 EDT","volume":1684,"amount":2211.648562,"timestamp":1790771564663,"change":0.005,"changeRate":0.003831,"amplitude":0.007663},"postHourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.26,"latestTime":"19:55 EDT","volume":591,"amount":755.78,"timestamp":1790812558759,"change":0.02,"changeRate":0.015873,"amplitude":0.015873},"volumeRatio":1.431865,"impliedVol":1.1448,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACXP\",,,,,undefined,":{"symbol":"ACXP","floatShares":5342700,"roa":"-55.92%","roe":"-128.11%","lyrEps":-5.315302,"volumeRatio":1.431865,"shares":5471300,"dividePrice":0,"high":1.32,"amplitude":0.068966,"preClose":1.305,"low":1.23,"week52Low":1.23,"pbRate":"0.85","week52High":8.34,"institutionHeld":0,"latestPrice":1.26,"eps":-3.0454,"divideRate":0,"volume":130497,"delay":0,"ttmEps":-3.0454,"open":1.32,"prevYearClose":2.49,"prevWeekClose":1.36,"prevMonthClose":1.45,"prevQuarterClose":1.55,"fiveDayClose":1.37,"twentyDayClose":1.4,"sixtyDayClose":1.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACXP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ACXP","fiscalQuarterEnding":"2026/06","expectedEps":-0.42,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.53},{"date":"2026-05-12","symbol":"ACXP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/03","expectedEps":-0.59,"defaultRemindTime":1778572800000,"name":null,"time":"Pre-MKt","dateTimestamp":1778558400000,"actualEps":null},{"market":"US","date":"2026-03-12","symbol":"ACXP","fiscalQuarterEnding":"2025/12","expectedEps":-1.01,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2025-11-12","symbol":"ACXP","fiscalQuarterEnding":"2025/09","expectedEps":-1.61,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-1.23},{"market":"US","date":"2025-08-12","symbol":"ACXP","fiscalQuarterEnding":"2025/06","expectedEps":2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACXP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACXP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1742356800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACXP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACXP","date":"2026-09-29","current":-0.413739,"percent":0.73494,"low":-7.237203,"twenty":-3.440996,"median":-2.134062,"eighty":-0.839143,"high":-0.374923,"avg":-2.261087,"sd":1.391445,"marketCap":7061694},"quantilePoints":[{"date":"2021-10-01","current":-6.68543,"twenty":-11.938223,"median":-9.998325,"eighty":-6.159321,"marketCap":52721073},{"date":"2021-10-08","current":-5.248255,"twenty":-11.938223,"median":-9.863911,"eighty":-5.992506,"marketCap":41387560},{"date":"2021-10-15","current":-6.300472,"twenty":-11.938223,"median":-7.333442,"eighty":-5.979674,"marketCap":49685311},{"date":"2021-10-22","current":-6.184985,"twenty":-11.938223,"median":-6.865077,"eighty":-5.979674,"marketCap":48774582},{"date":"2021-10-29","current":-6.41596,"twenty":-11.938223,"median":-6.794501,"eighty":-5.992506,"marketCap":50596040},{"date":"2021-11-05","current":-6.852245,"twenty":-11.938223,"median":-6.865077,"eighty":-6.031002,"marketCap":54036570},{"date":"2021-11-12","current":-4.527743,"twenty":-11.849101,"median":-6.858661,"eighty":-6.031002,"marketCap":50772486},{"date":"2021-11-19","current":-4.427531,"twenty":-11.828422,"median":-6.736758,"eighty":-5.966842,"marketCap":49648749},{"date":"2021-11-26","current":-4.454861,"twenty":-11.828422,"median":-6.68543,"eighty":-5.861621,"marketCap":49955222},{"date":"2021-12-03","current":-3.780711,"twenty":-11.762249,"median":-6.614854,"eighty":-5.699938,"marketCap":42395536},{"date":"2021-12-10","current":-3.835372,"twenty":-11.580273,"median":-6.557111,"eighty":-5.569053,"marketCap":43008484},{"date":"2021-12-17","current":-4.035795,"twenty":-11.522372,"median":-6.505783,"eighty":-5.166131,"marketCap":45255958},{"date":"2021-12-23","current":-4.32732,"twenty":-11.493421,"median":-6.428792,"eighty":-4.527743,"marketCap":48525012},{"date":"2021-12-31","current":-3.936859,"twenty":-11.476878,"median":-6.41596,"eighty":-4.409311,"marketCap":44146523},{"date":"2022-01-07","current":-4.017574,"twenty":-11.439656,"median":-6.358216,"eighty":-4.32732,"marketCap":45051642},{"date":"2022-01-14","current":-4.172447,"twenty":-11.104655,"median":-6.313304,"eighty":-4.289057,"marketCap":46788327},{"date":"2022-01-21","current":-3.316093,"twenty":-10.839963,"median":-6.223481,"eighty":-4.21982,"marketCap":37185482},{"date":"2022-01-28","current":-3.534737,"twenty":-10.695209,"median":-6.172153,"eighty":-4.137828,"marketCap":39637272},{"date":"2022-02-04","current":-3.589398,"twenty":-10.608357,"median":-6.159321,"eighty":-4.074057,"marketCap":40250220},{"date":"2022-02-11","current":-3.71694,"twenty":-10.550456,"median":-6.063082,"eighty":-4.024862,"marketCap":41680431},{"date":"2022-02-18","current":-3.73516,"twenty":-10.364344,"median":-5.979674,"eighty":-3.984778,"marketCap":41884747},{"date":"2022-02-25","current":-3.252322,"twenty":-10.194776,"median":-5.966842,"eighty":-3.953804,"marketCap":36470377},{"date":"2022-03-04","current":-3.252322,"twenty":-10.099653,"median":-5.896267,"eighty":-3.859058,"marketCap":36470377},{"date":"2022-03-11","current":-3.644059,"twenty":-10.029344,"median":-5.787196,"eighty":-3.791643,"marketCap":40863168},{"date":"2022-03-18","current":-2.922007,"twenty":-9.942491,"median":-5.68454,"eighty":-3.755202,"marketCap":37248855},{"date":"2022-03-25","current":-2.838922,"twenty":-9.913541,"median":-5.607549,"eighty":-3.720584,"marketCap":36189718},{"date":"2022-04-01","current":-2.737374,"twenty":-9.379631,"median":-5.44715,"eighty":-3.682321,"marketCap":34895218},{"date":"2022-04-08","current":-2.881869,"twenty":-7.43738,"median":-5.248255,"eighty":-3.645881,"marketCap":36737195},{"date":"2022-04-14","current":-3.210996,"twenty":-7.416849,"median":-4.609734,"eighty":-3.634948,"marketCap":40932808},{"date":"2022-04-22","current":-3.210996,"twenty":-7.250034,"median":-4.504968,"eighty":-3.534737,"marketCap":40932808},{"date":"2022-04-29","current":-3.003032,"twenty":-7.237203,"median":-4.427531,"eighty":-3.388974,"marketCap":38281743},{"date":"2022-05-06","current":-3.123797,"twenty":-7.121715,"median":-4.35465,"eighty":-3.315273,"marketCap":39821223},{"date":"2022-05-13","current":-1.994712,"twenty":-7.044724,"median":-4.32732,"eighty":-3.252322,"marketCap":27813277},{"date":"2022-05-20","current":-1.943188,"twenty":-7.01906,"median":-4.318209,"eighty":-3.210996,"marketCap":27094853},{"date":"2022-05-27","current":-1.923388,"twenty":-6.993396,"median":-4.236218,"eighty":-3.146776,"marketCap":26818773},{"date":"2022-06-03","current":-1.880623,"twenty":-6.942068,"median":-4.208888,"eighty":-3.079156,"marketCap":26222481},{"date":"2022-06-10","current":-2.774931,"twenty":-6.918971,"median":-4.158782,"eighty":-3.024918,"marketCap":38692271},{"date":"2022-06-17","current":-2.679244,"twenty":-6.906139,"median":-4.117786,"eighty":-2.999671,"marketCap":37358055},{"date":"2022-06-24","current":-2.716047,"twenty":-6.880475,"median":-4.090456,"eighty":-2.939922,"marketCap":37871215},{"date":"2022-07-01","current":-2.76021,"twenty":-6.857378,"median":-4.044905,"eighty":-2.90143,"marketCap":38487007},{"date":"2022-07-08","current":-2.760137,"twenty":-6.852245,"median":-4.026684,"eighty":-2.848154,"marketCap":38485981},{"date":"2022-07-15","current":-2.668203,"twenty":-6.80605,"median":-4.008464,"eighty":-2.820986,"marketCap":37204107},{"date":"2022-07-22","current":-2.657162,"twenty":-6.72136,"median":-3.972024,"eighty":-2.802901,"marketCap":37050159},{"date":"2022-07-29","current":-2.635081,"twenty":-6.693129,"median":-3.953804,"eighty":-2.779424,"marketCap":36742263},{"date":"2022-08-05","current":-2.88534,"twenty":-6.68543,"median":-3.921918,"eighty":-2.779424,"marketCap":40231751},{"date":"2022-08-12","current":-3.956018,"twenty":-6.664899,"median":-3.844482,"eighty":-2.782292,"marketCap":49687496},{"date":"2022-08-19","current":-3.519492,"twenty":-6.618704,"median":-3.839927,"eighty":-2.785236,"marketCap":44204738},{"date":"2022-08-26","current":-3.110248,"twenty":-6.585341,"median":-3.798931,"eighty":-2.789652,"marketCap":39064652},{"date":"2022-09-02","current":-3.073871,"twenty":-6.56481,"median":-3.780666,"eighty":-2.792596,"marketCap":38607755},{"date":"2022-09-09","current":-3.965112,"twenty":-6.551978,"median":-3.772829,"eighty":-2.798485,"marketCap":49801720},{"date":"2022-09-16","current":-3.542438,"twenty":-6.531447,"median":-3.78062,"eighty":-2.805846,"marketCap":44492944},{"date":"2022-09-23","current":-2.787945,"twenty":-6.521181,"median":-3.757935,"eighty":-2.805846,"marketCap":35016525},{"date":"2022-09-30","current":-2.760341,"twenty":-6.47242,"median":-3.73516,"eighty":-2.805846,"marketCap":34669827},{"date":"2022-10-07","current":-3.128387,"twenty":-6.436491,"median":-3.71694,"eighty":-2.811734,"marketCap":39292470},{"date":"2022-10-14","current":-2.714336,"twenty":-6.41596,"median":-3.689609,"eighty":-2.811734,"marketCap":34091996},{"date":"2022-10-21","current":-2.806347,"twenty":-6.41596,"median":-3.672742,"eighty":-2.791124,"marketCap":35247657},{"date":"2022-10-28","current":-3.027174,"twenty":-6.413394,"median":-3.653169,"eighty":-2.791124,"marketCap":38021243},{"date":"2022-11-04","current":-2.723537,"twenty":-6.395429,"median":-3.644059,"eighty":-2.783423,"marketCap":34207562},{"date":"2022-11-11","current":-2.94384,"twenty":-6.362066,"median":-3.619529,"eighty":-2.778468,"marketCap":33734492},{"date":"2022-11-18","current":-3.196747,"twenty":-6.346667,"median":-3.595377,"eighty":-2.782292,"marketCap":36632644},{"date":"2022-11-25","current":-2.953956,"twenty":-6.326136,"median":-3.588921,"eighty":-2.782292,"marketCap":33850418},{"date":"2022-12-02","current":-3.338375,"twenty":-6.313304,"median":-3.534737,"eighty":-2.787945,"marketCap":38255609},{"date":"2022-12-09","current":-3.743026,"twenty":-6.300472,"median":-3.538588,"eighty":-2.789652,"marketCap":42892653},{"date":"2022-12-16","current":-3.874538,"twenty":-6.223481,"median":-3.589398,"eighty":-2.789652,"marketCap":44399692},{"date":"2022-12-23","current":-3.975701,"twenty":-6.184985,"median":-3.603063,"eighty":-2.797013,"marketCap":45558953},{"date":"2022-12-30","current":-4.026282,"twenty":-6.174719,"median":-3.62058,"eighty":-2.802902,"marketCap":46138583},{"date":"2023-01-06","current":-4.501748,"twenty":-6.172153,"median":-3.638406,"eighty":-2.805558,"marketCap":51587110},{"date":"2023-01-13","current":-4.299422,"twenty":-6.164454,"median":-3.644059,"eighty":-2.809579,"marketCap":49268588},{"date":"2023-01-20","current":-4.258957,"twenty":-6.159321,"median":-3.653169,"eighty":-2.811734,"marketCap":48804883},{"date":"2023-01-27","current":-3.884654,"twenty":-6.149055,"median":-3.672742,"eighty":-2.8141,"marketCap":44515618},{"date":"2023-02-03","current":-3.540701,"twenty":-6.118259,"median":-3.662279,"eighty":-2.817733,"marketCap":40574131},{"date":"2023-02-10","current":-3.540701,"twenty":-6.069498,"median":-3.644059,"eighty":-2.819825,"marketCap":40574131},{"date":"2023-02-17","current":-3.70246,"twenty":-6.015604,"median":-3.644059,"eighty":-2.823936,"marketCap":42427789},{"date":"2023-02-24","current":-3.287793,"twenty":-5.98994,"median":-3.641863,"eighty":-2.825677,"marketCap":37675979},{"date":"2023-03-03","current":-3.641863,"twenty":-5.979674,"median":-3.638406,"eighty":-2.827332,"marketCap":41733392},{"date":"2023-03-10","current":-3.469887,"twenty":-5.977108,"median":-3.621631,"eighty":-2.83395,"marketCap":39762648},{"date":"2023-03-17","current":-3.021341,"twenty":-5.959143,"median":-3.604508,"eighty":-2.834944,"marketCap":36536396},{"date":"2023-03-24","current":-3.406225,"twenty":-5.925781,"median":-3.592246,"eighty":-2.839484,"marketCap":41190714},{"date":"2023-03-31","current":-3.329248,"twenty":-5.907816,"median":-3.59034,"eighty":-2.843856,"marketCap":40259850},{"date":"2023-04-06","current":-3.396603,"twenty":-5.877019,"median":-3.579746,"eighty":-2.852353,"marketCap":41074356},{"date":"2023-04-14","current":-2.751922,"twenty":-5.800028,"median":-3.550817,"eighty":-2.852353,"marketCap":33278373},{"date":"2023-04-21","current":-2.97323,"twenty":-5.787196,"median":-3.550817,"eighty":-2.848143,"marketCap":35954606},{"date":"2023-04-28","current":-2.866607,"twenty":-5.735868,"median":-3.540701,"eighty":-2.852353,"marketCap":34665231},{"date":"2023-05-05","current":-2.827999,"twenty":-5.710204,"median":-3.534737,"eighty":-2.841732,"marketCap":34198359},{"date":"2023-05-12","current":-3.19477,"twenty":-5.669142,"median":-3.525038,"eighty":-2.846189,"marketCap":38633641},{"date":"2023-05-19","current":-2.850337,"twenty":-5.633213,"median":-3.510352,"eighty":-2.847975,"marketCap":35132102},{"date":"2023-05-26","current":-2.937567,"twenty":-5.611399,"median":-3.474945,"eighty":-2.849898,"marketCap":36207255},{"date":"2023-06-02","current":-2.937567,"twenty":-5.59985,"median":-3.447184,"eighty":-2.851547,"marketCap":36207255},{"date":"2023-06-09","current":-2.808114,"twenty":-5.517726,"median":-3.439538,"eighty":-2.851547,"marketCap":34611681},{"date":"2023-06-16","current":-2.738409,"twenty":-5.4433,"median":-3.429421,"eighty":-2.847807,"marketCap":33752526},{"date":"2023-06-23","current":-2.569126,"twenty":-5.402238,"median":-3.402649,"eighty":-2.838681,"marketCap":31666006},{"date":"2023-06-30","current":-2.68862,"twenty":-5.340645,"median":-3.397344,"eighty":-2.829189,"marketCap":33138844},{"date":"2023-07-07","current":-2.540461,"twenty":-5.248255,"median":-3.388974,"eighty":-2.822775,"marketCap":31312689},{"date":"2023-07-14","current":-2.40399,"twenty":-4.837634,"median":-3.364889,"eighty":-2.811734,"marketCap":29630603},{"date":"2023-07-21","current":-2.361999,"twenty":-4.609734,"median":-3.350513,"eighty":-2.798157,"marketCap":29113038},{"date":"2023-07-28","current":-1.847608,"twenty":-4.542213,"median":-3.33875,"eighty":-2.787945,"marketCap":22772865},{"date":"2023-08-04","current":-2.21503,"twenty":-4.527743,"median":-3.338375,"eighty":-2.777512,"marketCap":27301560},{"date":"2023-08-11","current":-1.900097,"twenty":-4.527743,"median":-3.329248,"eighty":-2.760341,"marketCap":23419821},{"date":"2023-08-18","current":-1.869135,"twenty":-4.501748,"median":-3.318884,"eighty":-2.76021,"marketCap":24579691},{"date":"2023-08-25","current":-2.017479,"twenty":-4.482192,"median":-3.315273,"eighty":-2.741939,"marketCap":26530461},{"date":"2023-09-01","current":-1.908693,"twenty":-4.454861,"median":-3.304204,"eighty":-2.73148,"marketCap":25099897},{"date":"2023-09-08","current":-1.75046,"twenty":-4.432997,"median":-3.297891,"eighty":-2.723392,"marketCap":23019076},{"date":"2023-09-15","current":-1.710901,"twenty":-4.39109,"median":-3.28304,"eighty":-2.713206,"marketCap":22498871},{"date":"2023-09-22","current":-1.582336,"twenty":-4.374692,"median":-3.266474,"eighty":-2.696583,"marketCap":20808204},{"date":"2023-09-29","current":-1.463661,"twenty":-4.343718,"median":-3.252322,"eighty":-2.679128,"marketCap":19247589},{"date":"2023-10-06","current":-1.542778,"twenty":-4.329142,"median":-3.235119,"eighty":-2.671147,"marketCap":20287999},{"date":"2023-10-13","current":-4.034958,"twenty":-4.32732,"median":-3.237569,"eighty":-2.671147,"marketCap":53060922},{"date":"2023-10-20","current":-4.964581,"twenty":-4.374692,"median":-3.256877,"eighty":-2.671883,"marketCap":65285742},{"date":"2023-10-27","current":-4.667893,"twenty":-4.397094,"median":-3.266474,"eighty":-2.673013,"marketCap":61384204},{"date":"2023-11-03","current":-3.758049,"twenty":-4.476726,"median":-3.28304,"eighty":-2.677757,"marketCap":49419486},{"date":"2023-11-10","current":-3.708601,"twenty":-4.449395,"median":-3.283194,"eighty":-2.678778,"marketCap":48769230},{"date":"2023-11-17","current":-3.917109,"twenty":-4.422199,"median":-3.297873,"eighty":-2.680716,"marketCap":49840076},{"date":"2023-11-24","current":-4.187628,"twenty":-4.400873,"median":-3.300382,"eighty":-2.686605,"marketCap":53282070},{"date":"2023-12-01","current":-3.808902,"twenty":-4.38198,"median":-3.312639,"eighty":-2.68862,"marketCap":48463279},{"date":"2023-12-08","current":-4.696202,"twenty":-4.38198,"median":-3.318142,"eighty":-2.693965,"marketCap":59753020},{"date":"2023-12-15","current":-3.63577,"twenty":-4.37287,"median":-3.328111,"eighty":-2.697237,"marketCap":46260402},{"date":"2023-12-22","current":-3.884647,"twenty":-4.343718,"median":-3.333812,"eighty":-2.703555,"marketCap":49427037},{"date":"2023-12-29","current":-4.295835,"twenty":-4.333177,"median":-3.338375,"eighty":-2.706495,"marketCap":54658868},{"date":"2024-01-05","current":-4.285014,"twenty":-4.33643,"median":-3.338563,"eighty":-2.708536,"marketCap":54521188},{"date":"2024-01-12","current":-5.204777,"twenty":-4.400873,"median":-3.348492,"eighty":-2.708686,"marketCap":66223969},{"date":"2024-01-19","current":-4.328297,"twenty":-4.440176,"median":-3.358415,"eighty":-2.713206,"marketCap":55071908},{"date":"2024-01-26","current":-4.317476,"twenty":-4.429326,"median":-3.377159,"eighty":-2.715705,"marketCap":54934228},{"date":"2024-02-02","current":-3.527562,"twenty":-4.406205,"median":-3.396603,"eighty":-2.721877,"marketCap":44883605},{"date":"2024-02-09","current":-3.321968,"twenty":-4.385759,"median":-3.397158,"eighty":-2.723334,"marketCap":42267689},{"date":"2024-02-16","current":-3.300327,"twenty":-4.374692,"median":-3.388974,"eighty":-2.723392,"marketCap":41992329},{"date":"2024-02-23","current":-3.386893,"twenty":-4.359111,"median":-3.386893,"eighty":-2.723485,"marketCap":43093768},{"date":"2024-03-01","current":-3.105553,"twenty":-4.341834,"median":-3.386893,"eighty":-2.727023,"marketCap":39514093},{"date":"2024-03-08","current":-3.213761,"twenty":-4.33155,"median":-3.364889,"eighty":-2.730627,"marketCap":40890891},{"date":"2024-03-15","current":-2.932421,"twenty":-4.328297,"median":-3.350513,"eighty":-2.735016,"marketCap":37311217},{"date":"2024-03-22","current":-2.226653,"twenty":-4.328297,"median":-3.33875,"eighty":-2.723485,"marketCap":32459630},{"date":"2024-03-28","current":-2.518496,"twenty":-4.327906,"median":-3.338375,"eighty":-2.718962,"marketCap":36714047},{"date":"2024-04-05","current":-2.118563,"twenty":-4.32732,"median":-3.329248,"eighty":-2.706495,"marketCap":30883919},{"date":"2024-04-12","current":-2.021282,"twenty":-4.323676,"median":-3.321968,"eighty":-2.687411,"marketCap":29465780},{"date":"2024-04-19","current":-2.302316,"twenty":-4.318209,"median":-3.318884,"eighty":-2.674142,"marketCap":33562627},{"date":"2024-04-26","current":-2.183417,"twenty":-4.318209,"median":-3.315273,"eighty":-2.664523,"marketCap":31829346},{"date":"2024-05-03","current":-2.301105,"twenty":-4.317916,"median":-3.304204,"eighty":-2.652746,"marketCap":33544976},{"date":"2024-05-10","current":-2.192562,"twenty":-4.316324,"median":-3.29791,"eighty":-2.63511,"marketCap":31962666},{"date":"2024-05-17","current":-2.129106,"twenty":-4.308527,"median":-3.285571,"eighty":-2.616729,"marketCap":34177900},{"date":"2024-05-24","current":-2.57267,"twenty":-4.299422,"median":-3.281137,"eighty":-2.577025,"marketCap":41298296},{"date":"2024-05-31","current":-2.477227,"twenty":-4.298705,"median":-3.261432,"eighty":-2.56885,"marketCap":39766186},{"date":"2024-06-07","current":-2.368663,"twenty":-4.295086,"median":-3.249273,"eighty":-2.539607,"marketCap":38023444},{"date":"2024-06-14","current":-2.398272,"twenty":-4.291572,"median":-3.237569,"eighty":-2.530033,"marketCap":38498737},{"date":"2024-06-21","current":-2.299577,"twenty":-4.289508,"median":-3.235402,"eighty":-2.519465,"marketCap":36914427},{"date":"2024-06-28","current":-2.220622,"twenty":-4.285014,"median":-3.234651,"eighty":-2.502591,"marketCap":35646979},{"date":"2024-07-05","current":-2.033103,"twenty":-4.280355,"median":-3.233027,"eighty":-2.482891,"marketCap":32636790},{"date":"2024-07-12","current":-2.279839,"twenty":-4.271096,"median":-3.223405,"eighty":-2.467358,"marketCap":36597565},{"date":"2024-07-19","current":-2.398272,"twenty":-4.264513,"median":-3.212378,"eighty":-2.463479,"marketCap":38498737},{"date":"2024-07-26","current":-2.25023,"twenty":-4.25984,"median":-3.210996,"eighty":-2.445645,"marketCap":36122272},{"date":"2024-08-02","current":-2.08245,"twenty":-4.250864,"median":-3.208522,"eighty":-2.402846,"marketCap":33428945},{"date":"2024-08-09","current":-1.825588,"twenty":-4.246031,"median":-3.202969,"eighty":-2.384084,"marketCap":30540786},{"date":"2024-08-16","current":-1.951826,"twenty":-4.23804,"median":-3.197661,"eighty":-2.361358,"marketCap":32652648},{"date":"2024-08-23","current":-2.204301,"twenty":-4.236218,"median":-3.19477,"eighty":-2.345346,"marketCap":36876374},{"date":"2024-08-30","current":-2.136326,"twenty":-4.223316,"median":-3.188517,"eighty":-2.302074,"marketCap":35739217},{"date":"2024-09-06","current":-1.922694,"twenty":-4.219131,"median":-3.172148,"eighty":-2.286104,"marketCap":32165296},{"date":"2024-09-13","current":-1.980957,"twenty":-4.218492,"median":-3.165041,"eighty":-2.275891,"marketCap":33140001},{"date":"2024-09-20","current":-1.951826,"twenty":-4.21273,"median":-3.15797,"eighty":-2.265537,"marketCap":32652648},{"date":"2024-09-27","current":-1.86443,"twenty":-4.202511,"median":-3.146776,"eighty":-2.257421,"marketCap":31190590},{"date":"2024-10-04","current":-2.087774,"twenty":-4.19188,"median":-3.130117,"eighty":-2.249446,"marketCap":34926962},{"date":"2024-10-11","current":-2.010089,"twenty":-4.187628,"median":-3.128387,"eighty":-2.234788,"marketCap":33627354},{"date":"2024-10-18","current":-1.951826,"twenty":-4.187628,"median":-3.113033,"eighty":-2.220622,"marketCap":32652648},{"date":"2024-10-25","current":-1.786746,"twenty":-4.178519,"median":-3.10794,"eighty":-2.213319,"marketCap":29890982},{"date":"2024-11-01","current":-1.806167,"twenty":-4.166981,"median":-3.100143,"eighty":-2.203947,"marketCap":30215884},{"date":"2024-11-08","current":-1.806167,"twenty":-4.157871,"median":-3.088695,"eighty":-2.19356,"marketCap":30215884},{"date":"2024-11-15","current":-1.767787,"twenty":-4.150298,"median":-3.081142,"eighty":-2.181144,"marketCap":29055182},{"date":"2024-11-22","current":-1.387508,"twenty":-4.135209,"median":-3.07318,"eighty":-2.149641,"marketCap":22804939},{"date":"2024-11-29","current":-1.284729,"twenty":-4.125219,"median":-3.065235,"eighty":-2.140727,"marketCap":21115685},{"date":"2024-12-06","current":-0.770838,"twenty":-4.120736,"median":-3.05063,"eighty":-2.136326,"marketCap":12669411},{"date":"2024-12-13","current":-0.878858,"twenty":-4.111282,"median":-3.042419,"eighty":-2.129883,"marketCap":14444817},{"date":"2024-12-20","current":-0.847921,"twenty":-4.10134,"median":-3.035027,"eighty":-2.112058,"marketCap":13936352},{"date":"2024-12-27","current":-0.918838,"twenty":-4.100763,"median":-3.029808,"eighty":-2.097994,"marketCap":15101937},{"date":"2025-01-03","current":-0.914624,"twenty":-4.099566,"median":-3.026769,"eighty":-2.087774,"marketCap":15032678},{"date":"2025-01-10","current":-0.830655,"twenty":-4.092278,"median":-3.023853,"eighty":-2.081672,"marketCap":13652557},{"date":"2025-01-17","current":-0.907533,"twenty":-4.090284,"median":-3.019134,"eighty":-2.067585,"marketCap":14916119},{"date":"2025-01-24","current":-0.895816,"twenty":-4.090241,"median":-3.010309,"eighty":-2.058642,"marketCap":14723544},{"date":"2025-01-31","current":-0.750899,"twenty":-4.090241,"median":-2.997753,"eighty":-2.043977,"marketCap":12341695},{"date":"2025-02-07","current":-0.795813,"twenty":-4.088284,"median":-2.986227,"eighty":-2.027397,"marketCap":13079899},{"date":"2025-02-14","current":-0.762615,"twenty":-4.072667,"median":-2.973442,"eighty":-2.016716,"marketCap":12534270},{"date":"2025-02-21","current":-0.804343,"twenty":-4.056659,"median":-2.970335,"eighty":-2.010243,"marketCap":13220108},{"date":"2025-02-28","current":-0.729212,"twenty":-4.04696,"median":-2.964072,"eighty":-1.994631,"marketCap":11985262},{"date":"2025-03-07","current":-0.470005,"twenty":-4.046781,"median":-2.953761,"eighty":-1.988678,"marketCap":7724962},{"date":"2025-03-14","current":-0.534112,"twenty":-4.045871,"median":-2.953473,"eighty":-1.982077,"marketCap":8778614},{"date":"2025-03-21","current":-0.661755,"twenty":-4.044905,"median":-2.944364,"eighty":-1.980421,"marketCap":9332799},{"date":"2025-03-28","current":-0.638311,"twenty":-4.041261,"median":-2.937567,"eighty":-1.964134,"marketCap":9002161},{"date":"2025-04-04","current":-0.500145,"twenty":-4.03546,"median":-2.933581,"eighty":-1.951826,"marketCap":7053603},{"date":"2025-04-11","current":-0.553755,"twenty":-4.032484,"median":-2.92512,"eighty":-1.947591,"marketCap":7809661},{"date":"2025-04-17","current":-0.58267,"twenty":-4.028274,"median":-2.922007,"eighty":-1.938558,"marketCap":8217448},{"date":"2025-04-25","current":-0.632371,"twenty":-4.026282,"median":-2.909973,"eighty":-1.922833,"marketCap":8918399},{"date":"2025-05-02","current":-0.645031,"twenty":-4.026089,"median":-2.905875,"eighty":-1.915453,"marketCap":9096944},{"date":"2025-05-09","current":-0.562664,"twenty":-4.023768,"median":-2.898358,"eighty":-1.909551,"marketCap":7935303},{"date":"2025-05-16","current":-0.71839,"twenty":-4.016958,"median":-2.893258,"eighty":-1.899063,"marketCap":8530451},{"date":"2025-05-23","current":-0.73918,"twenty":-4.01329,"median":-2.887777,"eighty":-1.872577,"marketCap":8777327},{"date":"2025-05-30","current":-0.717833,"twenty":-4.008464,"median":-2.885625,"eighty":-1.86443,"marketCap":8523839},{"date":"2025-06-06","current":-0.687081,"twenty":-4.008464,"median":-2.879956,"eighty":-1.85472,"marketCap":8158684},{"date":"2025-06-13","current":-0.652772,"twenty":-4.00605,"median":-2.871746,"eighty":-1.84598,"marketCap":7751278},{"date":"2025-06-20","current":-1.423798,"twenty":-4.00415,"median":-2.862255,"eighty":-1.845009,"marketCap":16906756},{"date":"2025-06-27","current":-0.947419,"twenty":-4.003675,"median":-2.857787,"eighty":-1.834155,"marketCap":11250037},{"date":"2025-07-03","current":-0.953154,"twenty":-3.997446,"median":-2.850337,"eighty":-1.826753,"marketCap":11318134},{"date":"2025-07-11","current":-0.986771,"twenty":-3.99303,"median":-2.844518,"eighty":-1.817857,"marketCap":11717321},{"date":"2025-07-18","current":-1.111951,"twenty":-3.991288,"median":-2.838521,"eighty":-1.811994,"marketCap":13203761},{"date":"2025-07-25","current":-1.094616,"twenty":-3.985317,"median":-2.830974,"eighty":-1.796456,"marketCap":12997912},{"date":"2025-08-01","current":-0.807341,"twenty":-3.981494,"median":-2.825677,"eighty":-1.786746,"marketCap":9586695},{"date":"2025-08-08","current":-0.602367,"twenty":-3.977874,"median":-2.817754,"eighty":-1.767581,"marketCap":7152755},{"date":"2025-08-15","current":-0.770288,"twenty":-3.969348,"median":-2.811734,"eighty":-1.75046,"marketCap":7702006},{"date":"2025-08-22","current":-0.721155,"twenty":-3.963793,"median":-2.80536,"eighty":-1.724968,"marketCap":7210726},{"date":"2025-08-29","current":-0.756024,"twenty":-3.958776,"median":-2.798157,"eighty":-1.697056,"marketCap":7559376},{"date":"2025-09-05","current":-0.611793,"twenty":-3.955132,"median":-2.789652,"eighty":-1.646476,"marketCap":6117231},{"date":"2025-09-12","current":-0.676776,"twenty":-3.953804,"median":-2.785119,"eighty":-1.558601,"marketCap":6766989},{"date":"2025-09-19","current":-0.687871,"twenty":-3.950423,"median":-2.778241,"eighty":-1.48344,"marketCap":6877923},{"date":"2025-09-26","current":-0.613613,"twenty":-3.941955,"median":-2.772237,"eighty":-1.425726,"marketCap":6135432},{"date":"2025-10-03","current":-0.696039,"twenty":-3.932705,"median":-2.760341,"eighty":-1.390278,"marketCap":6959595},{"date":"2025-10-10","current":-1.135642,"twenty":-3.925931,"median":-2.760275,"eighty":-1.273413,"marketCap":11355128},{"date":"2025-10-17","current":-1.07306,"twenty":-3.922017,"median":-2.760137,"eighty":-1.189811,"marketCap":10729375},{"date":"2025-10-24","current":-0.992161,"twenty":-3.917261,"median":-2.747749,"eighty":-1.154085,"marketCap":9920475},{"date":"2025-10-31","current":-0.778464,"twenty":-3.917109,"median":-2.738409,"eighty":-1.120028,"marketCap":7783757},{"date":"2025-11-07","current":-0.763201,"twenty":-3.908453,"median":-2.734427,"eighty":-1.099569,"marketCap":7631135},{"date":"2025-11-14","current":-0.723514,"twenty":-3.895189,"median":-2.723537,"eighty":-1.078885,"marketCap":7234315},{"date":"2025-11-21","current":-0.889174,"twenty":-3.890724,"median":-2.723334,"eighty":-1.044867,"marketCap":8153769},{"date":"2025-11-28","current":-0.882351,"twenty":-3.884653,"median":-2.715191,"eighty":-1.007961,"marketCap":8091208},{"date":"2025-12-05","current":-0.791387,"twenty":-3.882625,"median":-2.708536,"eighty":-0.992466,"marketCap":7257063},{"date":"2025-12-12","current":-0.934656,"twenty":-3.874538,"median":-2.695601,"eighty":-0.987318,"marketCap":8570841},{"date":"2025-12-19","current":-0.784565,"twenty":-3.874396,"median":-2.686605,"eighty":-0.966996,"marketCap":7194502},{"date":"2025-12-26","current":-0.786839,"twenty":-3.873826,"median":-2.678662,"eighty":-0.959671,"marketCap":7215355},{"date":"2026-01-02","current":-0.566251,"twenty":-3.85241,"median":-2.671883,"eighty":-0.952007,"marketCap":5192553},{"date":"2026-01-09","current":-0.747704,"twenty":-3.844997,"median":-2.666363,"eighty":-0.935216,"marketCap":6856489},{"date":"2026-01-16","current":-0.68881,"twenty":-3.844248,"median":-2.663917,"eighty":-0.925448,"marketCap":6316423},{"date":"2026-01-23","current":-0.711856,"twenty":-3.844189,"median":-2.657162,"eighty":-0.914686,"marketCap":6527754},{"date":"2026-01-30","current":-0.638878,"twenty":-3.844189,"median":-2.644465,"eighty":-0.908766,"marketCap":5858541},{"date":"2026-02-06","current":-0.52749,"twenty":-3.842494,"median":-2.635081,"eighty":-0.897912,"marketCap":4837112},{"date":"2026-02-13","current":-0.52767,"twenty":-3.837769,"median":-2.624617,"eighty":-0.882351,"marketCap":4838762},{"date":"2026-02-20","current":-0.513784,"twenty":-3.829064,"median":-2.605638,"eighty":-0.877563,"marketCap":4711426},{"date":"2026-02-27","current":-0.455462,"twenty":-3.817298,"median":-2.583557,"eighty":-0.864801,"marketCap":4176615},{"date":"2026-03-06","current":-0.402695,"twenty":-3.81384,"median":-2.569015,"eighty":-0.851599,"marketCap":3692739},{"date":"2026-03-13","current":-1.391383,"twenty":-3.811865,"median":-2.559168,"eighty":-0.850637,"marketCap":12759052},{"date":"2026-03-20","current":-2.37604,"twenty":-3.808558,"median":-2.539927,"eighty":-0.851268,"marketCap":18928815},{"date":"2026-03-27","current":-1.437092,"twenty":-3.807823,"median":-2.539252,"eighty":-0.851599,"marketCap":11448650},{"date":"2026-04-02","current":-1.394087,"twenty":-3.805784,"median":-2.529963,"eighty":-0.852874,"marketCap":11106047},{"date":"2026-04-10","current":-0.964034,"twenty":-3.797109,"median":-2.522588,"eighty":-0.858622,"marketCap":7680017},{"date":"2026-04-17","current":-0.892359,"twenty":-3.789309,"median":-2.516705,"eighty":-0.863338,"marketCap":7109012},{"date":"2026-04-24","current":-0.926236,"twenty":-3.78726,"median":-2.504713,"eighty":-0.858622,"marketCap":7378896},{"date":"2026-05-01","current":-0.995358,"twenty":-3.78595,"median":-2.487972,"eighty":-0.863338,"marketCap":7929560},{"date":"2026-05-08","current":-0.976926,"twenty":-3.780693,"median":-2.477227,"eighty":-0.86407,"marketCap":7782717},{"date":"2026-05-15","current":-0.949801,"twenty":-3.77762,"median":-2.467358,"eighty":-0.867868,"marketCap":7121920},{"date":"2026-05-22","current":-0.944905,"twenty":-3.765503,"median":-2.46202,"eighty":-0.871417,"marketCap":7085209},{"date":"2026-05-29","current":-0.974281,"twenty":-3.765038,"median":-2.452554,"eighty":-0.871663,"marketCap":7305475},{"date":"2026-06-05","current":-1.009949,"twenty":-3.763259,"median":-2.437749,"eighty":-0.876699,"marketCap":7572930},{"date":"2026-06-12","current":-0.941478,"twenty":-3.758937,"median":-2.40399,"eighty":-0.878426,"marketCap":7059511},{"date":"2026-06-18","current":-0.878713,"twenty":-3.754514,"median":-2.393492,"eighty":-0.878713,"marketCap":6588877},{"date":"2026-06-26","current":-0.813886,"twenty":-3.732595,"median":-2.36717,"eighty":-0.867868,"marketCap":6102787},{"date":"2026-07-02","current":-0.876934,"twenty":-3.711863,"median":-2.348925,"eighty":-0.867837,"marketCap":6575539},{"date":"2026-07-10","current":-0.836813,"twenty":-3.697459,"median":-2.302316,"eighty":-0.861944,"marketCap":6274697},{"date":"2026-07-17","current":-0.911324,"twenty":-3.673554,"median":-2.280698,"eighty":-0.86011,"marketCap":6833403},{"date":"2026-07-24","current":-0.831081,"twenty":-3.644059,"median":-2.268542,"eighty":-0.853838,"marketCap":6231720},{"date":"2026-07-31","current":-0.813886,"twenty":-3.641863,"median":-2.258384,"eighty":-0.850324,"marketCap":6102787},{"date":"2026-08-07","current":-0.836813,"twenty":-3.614128,"median":-2.249251,"eighty":-0.842544,"marketCap":6274697},{"date":"2026-08-14","current":-0.848276,"twenty":-3.591282,"median":-2.230633,"eighty":-0.842544,"marketCap":6360652},{"date":"2026-08-21","current":-1.018007,"twenty":-3.571049,"median":-2.217819,"eighty":-0.839143,"marketCap":7641385},{"date":"2026-08-28","current":-1.025028,"twenty":-3.550817,"median":-2.204668,"eighty":-0.839143,"marketCap":7694084},{"date":"2026-09-04","current":-0.982903,"twenty":-3.534737,"median":-2.193394,"eighty":-0.839143,"marketCap":7377889},{"date":"2026-09-11","current":-0.982903,"twenty":-3.519492,"median":-2.181144,"eighty":-0.839143,"marketCap":7377889},{"date":"2026-09-18","current":-0.975883,"twenty":-3.490119,"median":-2.143852,"eighty":-0.839143,"marketCap":7325190},{"date":"2026-09-25","current":-0.95482,"twenty":-3.449654,"median":-2.136326,"eighty":-0.839143,"marketCap":7167092},{"date":"2026-09-29","current":-0.940779,"twenty":-3.440996,"median":-2.134062,"eighty":-0.839143,"marketCap":7061694}],"updateTime":1790810032597},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACXP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2656537612","title":"Acurx Says FDA Open to Single Phase 3 Trial to Support Ibezapolstat CDI NDA Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2656537612","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656537612?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:04","pubTimestamp":1785758696,"startTime":"0","endTime":"0","summary":"Acurx says FDA open to single Phase 3 trial to support ibezapolstat CDI NDA filingAcurx received FDA guidance on its ibezapolstat Phase 3 plan for C. difficile infection, including a possible single-t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDLP8YQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP","BK4539","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656376669","title":"Acurx Pharmaceuticals - Receives FDA Guidance on Single Phase 3 Trial Nda for Ibezapolstat in Cdi","url":"https://stock-news.laohu8.com/highlight/detail?id=2656376669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656376669?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:00","pubTimestamp":1785758425,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN4400Q1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACXP","BK4563","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656376666","title":"FDA Provides Further Regulatory Guidance to Acurx Pharmaceuticals for the Ibezapolstat Clinical Development Program, Including the Potential for a Single-Phase 3-Trial Registration Plan and a Trial Design to Support Both Treatment and Reduction of Recurrence of C. Difficile Infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2656376666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656376666?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:00","pubTimestamp":1785758425,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN4400Q1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","BK4563","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656376664","title":"Acurx Pharmaceuticals - FDA Agrees Nda Filing Possible for Both Treatment and Recurrence Reduction with Successful Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2656376664","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656376664?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:00","pubTimestamp":1785758425,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN4400Q1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4563","BK4539","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656376609","title":"Acurx Pharmaceuticals - FDA Open to Pre-Nda Discussion After Single Phase 3 Trial if Efficacy Results are Robust","url":"https://stock-news.laohu8.com/highlight/detail?id=2656376609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656376609?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:00","pubTimestamp":1785758425,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN4400Q1:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","ACXP","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651380103","title":"Acurx Launches Pilot Trial of Ibezapolstat in Multiply Recurrent C. Difficile Infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2651380103","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651380103?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:03","pubTimestamp":1784030599,"startTime":"0","endTime":"0","summary":"Acurx launches pilot trial of ibezapolstat in multiply recurrent C. difficile infectionAcurx initiated start-up activities for a clinical trial of ibezapolstat in multiply recurrent C. difficile infec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL2dWFTP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP","BK4139","BK4563","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651116452","title":"Acurx Pharmaceuticals Posts Presentation on Ibezapolstat Microbiome Restoration Potential in Recurrent C. Difficile Infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2651116452","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651116452?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:37","pubTimestamp":1783942625,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals posts presentation on ibezapolstat microbiome restoration potential in recurrent C. difficile infectionAcurx published research comparing ibezapolstat with fidaxomicin, vancomyci","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL8DG2bg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4563","ACXP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649774993","title":"Acurx Pharmaceuticals to Discuss Q2 Financial Results on Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2649774993","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649774993?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:01","pubTimestamp":1783512068,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals to discuss Q2 financial results on conference callAcurx schedules a conference call on Aug. 14, 2026, at 8:00 a.m. ET to discuss Q2 2026 financial results.Disclaimer:This news br","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL8SkVYH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ACXP","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649268993","title":"Acurx Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 14, 2026 Conference Call and Provide Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2649268993","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649268993?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:00","pubTimestamp":1783512007,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUA3XH5TD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACXP","BK4139","BK4539","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643754735","title":"Acurx says lead antibiotic ibezapolstat is ready to enter pivotal Phase 3 trials for C. difficile infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2643754735","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643754735?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:03","pubTimestamp":1781611390,"startTime":"0","endTime":"0","summary":"Acurx highlighted new mechanistic findings on its antibiotic candidate ibezapolstat, presented June 11, 2026 at the LED3 scientific conference.The work supports a selective, targeted mechanism against Gram-positive bacteria, reinforcing the drug’s potential positioning in hard-to-treat infections.Ibezapolstat remains slated to advance into international pivotal Phase 3 trials for C. difficile infection, a key value driver for the program.The update also underpins earlier-stage efforts to expand into additional Gram-positive indications, including a planned oral program for ABSSSI.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL9wzKnx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","ACXP","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643754439","title":"Acurx Pharmaceuticals Announces Presentation of Results From Leiden University Medical Center Public-Private Partnership for Its DNA Pol Iiic Inhibitors at the Leiden Early Drug Discovery & Development (Led3) Scientific Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2643754439","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643754439?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:00","pubTimestamp":1781611222,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUA7WVJ9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ACXP","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635673224","title":"Analysts Conflicted on These Healthcare Names: Altimmune (ALT) and Acurx Pharmaceuticals (ACXP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635673224","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635673224?lang=en_us&edition=fundamental","pubTime":"2026-05-14 02:20","pubTimestamp":1778696408,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Altimmune (ALT) and Acurx Pharmaceuticals (ACXP). Altimmune (ALT)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-altimmune-alt-and-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-altimmune-alt-and-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","ALT","BK4539","LU0029874061.USD","LU1878469433.USD","BK4137","LU0128526141.USD","BK4585","BK4599","BK4588","BK4563","LABU","BK4139","BK4581","ACXP","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635787121","title":"Analysts Are Bullish on Top Healthcare Stocks: Acurx Pharmaceuticals (ACXP), Neurogene (NGNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635787121","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635787121?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:00","pubTimestamp":1778677245,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Acurx Pharmaceuticals (ACXP) and Neurogene (NGNE) wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-acurx-pharmaceuticals-acxp-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-acurx-pharmaceuticals-acxp-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACXP","BK4137","BK4539","BK4563","LU0128526141.USD","LU0029874061.USD","BK4112","BK4139","BK4585","BK4588","BLSX","XBI","BLSG","BK4581","NGNE","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634212782","title":"Acurx Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634212782","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634212782?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:31","pubTimestamp":1778592667,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings SummaryAcurx Pharmaceuticals Inc ACXP.OQ reported a quarterly adjusted loss of 62 cents per share for the quarter en","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P1XT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4563","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215919","title":"Acurx Pharmaceuticals Q1 EPS USD -0.62","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215919","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215919?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:32","pubTimestamp":1778585530,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nPLX3F733D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4539","BK4139","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634126237","title":"Acurx Q1 net loss narrows 22% to $1.68 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634126237","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634126237?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:15","pubTimestamp":1778530559,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals posted a net loss of $1.68 million, narrowing 22% from prior-year period.Operating loss improved 21% to $1.72 million as operating expenses fell 21% to $1.72 million.Research and development expense dropped 43% to $341,000, while general and administrative costs decreased 13% to $1.38 million.Cash totaled about $9.3 million at March 31, 2026, following net cash used in operating activities of $1.41 million.April 2026 registered direct offering raised about $2.5 million in gross proceeds; company also launched a recurrent C. difficile infection initiative with an open-label pilot trial expected to begin enrolling in Q4.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLTzQ7l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","ACXP","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634020034","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2634020034","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634020034?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:00","pubTimestamp":1778493600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·ATL Braves C                                   1Q      (.78)   8:00 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BETA","AIP","B","ASTS","CEG","COOK","BRCB","AMTM","ANDG","CDRE","BCAX","BODI","ABCL","CVRX","ALGS","CBLL","AEYE","ACHV","ASRT","CHRS","CINT","BALY","ACET","ACH","BLNK","BATRK","ARMK","AMBQ","BGS","ALLT","CLSK","ACRS","AGNT","BTAI","CERT","CEVA","BCSF","APC","ARVN","ACM","CLLS","ATRO","BATRA","BIOA","DCGO","ACXP","CRCL","CGBD","APEI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633468695","title":"Acurx Pharmaceuticals Inc  expected to post a loss of 63 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633468695","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633468695?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:38","pubTimestamp":1778254688,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc  expected to post a loss of63cents a share - Earnings Preview Acurx Pharmaceuticals Inc ACXP.OQ ACXP.O is expected to  show no change in quarterly revenue when it reports  re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L1WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4563","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632434958","title":"Acurx DNA pol IIIC inhibitors spare gut microbiome in MRSA mouse study, poster shows","url":"https://stock-news.laohu8.com/highlight/detail?id=2632434958","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632434958?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:01","pubTimestamp":1777896105,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals announced microbiome data on its preclinical DNA pol IIIC inhibitor antibiotics were presented in a scientific poster at ESCMID Global 2026 in Munich, held April 17-21.In a mouse MRSA infection model, the compounds showed systemic antibacterial activity while preserving gut microbiome diversity and baseline-like community structure, contrasting with linezolid.The results support a potential class effect that could differentiate the program by aiming to treat serious Gram-positive infections while reducing risk of antibiotic-driven dysbiosis.Acurx said its DNA pol IIIC inhibitor candidates are positioned for FDA QIDP and Fast-Track eligibility, signaling a regulatory pathway aimed at accelerating development for high-need infections.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL923BSh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACXP","BK4539","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631516945","title":"Acurx CEO to join Alliance Global Partners Healthcare Company Showcase fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2631516945","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631516945?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:00","pubTimestamp":1777464045,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals CEO David P. Luci set to join a virtual fireside chat at Alliance Global Partners Healthcare Company Showcase on May 24, 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL1wF8W8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP","BK4563","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}]}}